AstraZeneca (NASDAQ:AZN) announced Tuesday that an expert panel of the EU drug regulator, the European Medicines Agency (EMA) ...

AstraZeneca continues to impress me with the strong performances of its oncology, cardiovascular, and rare disease franchises ...

A Google Translate screenshot correctly shows that the name of the pharmaceutical company AstraZeneca, when written as “A ...

EMA committee recommends approval of AstraZeneca’s Imfinzi to treat adult patients with resectable muscle-invasive bladder cancer: Cambridge, UK Tuesday, May 27, 2025, 15:00 Hrs ...

AstraZeneca is putting the pedal to the metal to drive up early detection of prostate cancer. | AstraZeneca is putting the ...

A consultancy’s new ranking of drug company R&D shows Eli Lilly has risen to the top of the drug development heap, while ...

They're produced by an industry-leading manufacturer, but one U.S. agency warns of a defect concerning this well known ...

AstraZeneca completes acquisition of biotech company, EsoBiotec: Cambridge, UK Wednesday, May 21, 2025, 09:00 Hrs [IST] AstraZeneca announced the successful completion of the acqu ...

Tempus AI delivered strong Q1 results, driven by the Ambry Genetics acquisition and a major AstraZeneca contract, boosting ...

The project’s first phase will establish Sweden’s largest enterprise AI supercomputer by deploying two Nvidia DGX SuperPODs ...

The AstraZeneca PLC ADR AZN rose 1.25% to $68.81 Friday, on what proved to be an all-around positive trading session for the ...